Tirbanibulin Patent Expiration
Tirbanibulin is Used for treating actinic keratosis on the face or scalp. It was first introduced by Almirall Llc
Tirbanibulin Patents
Given below is the list of patents protecting Tirbanibulin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Klisyri | US10669236 | Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide | Sep 07, 2038 | Almirall |
| Klisyri | US10617693 | Methods of treating and/or preventing actinic keratosis | Mar 12, 2038 | Almirall |
| Klisyri | US11497750 | Methods of treating and/or preventing actinic keratosis | Mar 12, 2038 | Almirall |
| Klisyri | US7851470 | Composition and methods for modulating a kinase cascade | Feb 02, 2029 | Almirall |
| Klisyri | US10323001 | Compositions for modulating a kinase cascade and methods of use thereof | Dec 28, 2027 | Almirall |
| Klisyri | US7300931 | Compositions for treating cell proliferation disorders | Feb 06, 2026 | Almirall |
| Klisyri | US8236799 | Biaryl compositions and methods for modulating a kinase cascade | Dec 28, 2025 | Almirall |
| Klisyri | US8980890 | Compositions and methods of treating cell proliferation disorders | Dec 28, 2025 | Almirall |
Tirbanibulin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List